← Open Payments lookup

MICHAEL MCNAMARA: Open Payments

NPI 1861477259 · MANCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$255,678 in 303 payments from 14 companies in 2025. Trend: 2023 $110,986 · 2024 $164,244 · 2025 $255,678

Speaker / faculty: $163,889Consulting: $31,981Travel & lodging: $29,738Honoraria: $21,725Food & beverage: $8,346
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.60$62,055
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)42$45,373
Otsuka America Pharmaceutical, Inc.31$37,810
Neurocrine BioSciences, Inc.35$37,807
Axsome Therapeutics, Inc.26$23,872
Alkermes, Inc.38$17,499
Teva Pharmaceuticals USA, Inc.15$14,895
Janssen Pharmaceuticals, Inc20$13,069
ABBVIE INC.8$2,475
Vanda Pharmaceuticals Inc.24$455

Products named: COBENFY, CAPLYTA, INGREZZA, REXULTI, Auvelity, LYBALVI, UZEDY, INVEGA SUSTENNA.

Industry payments across NH — which companies pay providers there.